| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.38B | 36.53B | 37.99B | 39.34B | 34.82B | 32.44B |
| Gross Profit | 7.74B | 7.66B | 7.42B | 7.19B | 6.30B | 5.50B |
| EBITDA | 5.17B | 5.06B | 4.93B | 4.92B | 4.23B | 3.54B |
| Net Income | 2.04B | 2.04B | 1.99B | 2.15B | 1.74B | 1.33B |
Balance Sheet | ||||||
| Total Assets | 39.34B | 41.20B | 42.89B | 41.06B | 37.31B | 34.67B |
| Cash, Cash Equivalents and Short-Term Investments | 7.97B | 9.03B | 7.18B | 6.25B | 7.98B | 8.17B |
| Total Debt | 2.11B | 1.55B | 1.81B | 2.21B | 1.78B | 1.66B |
| Total Liabilities | 13.77B | 15.54B | 18.19B | 18.34B | 16.43B | 15.10B |
| Stockholders Equity | 25.57B | 25.66B | 24.69B | 22.72B | 20.88B | 19.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.82B | 3.29B | -750.00M | 273.00M | 2.52B |
| Operating Cash Flow | 0.00 | 4.94B | 5.25B | 1.69B | 2.73B | 5.66B |
| Investing Cash Flow | 0.00 | -2.18B | -2.45B | -2.85B | -2.33B | -2.95B |
| Financing Cash Flow | 0.00 | -951.00M | -1.88B | -637.00M | -619.00M | -502.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥35.47B | 8.57 | ― | 1.78% | 7.40% | 24.45% | |
77 Outperform | ¥18.72B | 5.76 | ― | 3.81% | -4.60% | -4.11% | |
73 Outperform | ¥53.57B | 13.47 | ― | 3.00% | 10.00% | 12.37% | |
72 Outperform | ¥33.46B | 9.39 | ― | 4.05% | 5.23% | 0.62% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥68.98B | 15.26 | ― | 3.17% | 4.04% | 7.40% | |
61 Neutral | ¥142.63B | 9.09 | ― | 2.42% | 8.46% | -3.62% |